Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05755295

Feasibility and Acceptability of Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma

Conditions: Neuroblastoma

Sex: All
Ages: 10 Years – 26 Years
Phase: NA
Enrollment: 15
Sponsor: University Hospital, Toulouse

Summary

On average, each year in the former region, 60 new patients under the age of 18 are treated for a brain tumor, with an active post-treatment follow-up file of 350 patients. Because of the significant sequelae induced by the disease or the treatments, these patients will very often require rehabilitative care.The interest of involving the horse in the population of patients cured of a medulloblastoma but with important physical and psychological after-effects is to be able to combine a therapy using animal mediation (equitherapy) and a rehabilitation therapy based on the three-dimensional movement of the horse (hippotherapy).

Eligibility Criteria

Inclusion Criteria:complete remission of medulloblastoma and after 5 years of the end of treatmentliving within 30 km away the riding center and/or less than 1 hour of transportinformed consentExclusion Criteria:Landsky score below 50% for minors until 16 years old and Karnofsky score below 50% for patients over 16 yearsmajor under juridical protection

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05755295). StuddyBuddy aggregates publicly available trial information.